Cutler Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$1K | – | 2186 |
|
|
2023
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1380 |
|
|
2022
Q4 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 2584 |
|
|
2022
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1858 |
|
|
2022
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1748 |
|
|
2022
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1846 |
|
|
2021
Q4 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 1866 |
|
|
2021
Q3 | – | Sell |
-700
| Closed | -$11K | – | 2946 |
|
|
2021
Q2 | $11K | Buy |
700
+100
| +17% | +$1.57K | ﹤0.01% | 1702 |
|
|
2021
Q1 | $13K | Sell |
600
-1,000
| -63% | -$21.7K | ﹤0.01% | 1576 |
|
|
2020
Q4 | $49K | Buy |
1,600
+1,300
| +433% | +$39.8K | ﹤0.01% | 1016 |
|
|
2020
Q3 | $6K | Sell |
300
-800
| -73% | -$16K | ﹤0.01% | 1420 |
|
|
2020
Q2 | $16K | Buy |
+1,100
| New | +$16K | ﹤0.01% | 1146 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2230 |
|